Key facts
- It has raised $1.5M; the latest was Early Stage VC ($1.2M) in Dec 2025.
- Notable investors include Venture Kick, Ecole Polytechnique Federale de Lausanne, Kickfund, Founderful Campus.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Bioscibex
- ·The full record, as it builds
Funding rounds
No funding rounds for Bioscibex are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bioscibex
Developer of a single-use bioreactor designed for simplifying and accelerating cell culture processes. The company offers a fully automated, closed system with integrated sensors for monitoring DO (dissolved oxygen), pH, and pCO2 (partial pressure of carbon dioxide), and capacitance-based cell counting, enabling clients to scale cell expansion from vial thawing to large-scale production with minimal manual work, reduced investment, and lower process costs.
- Sector
- Healthcare
- HQ
- Monthey, Switzerland
- Founded
- 2024
- Employees
- 6
- Website
- bioscibex.com/
- Ownership
- Privately Held (backing)
Bioscibex doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bioscibex shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bioscibex in its N-PORT filings yet. We sweep new filings monthly.